Results 231 to 240 of about 3,775,993 (302)

Drug retention of biologic and targeted synthetic disease-modifying antirheumatic drugs in Korean patients with seropositive rheumatoid arthritis. [PDF]

Korean J Intern Med
Lee BW, Lee JJ, Kim WU.
europepmc   +1 more source

Predictors at diagnosis for start of biologic disease-modifying antirheumatic drugs in patients with early rheumatoid arthritis: a cohort study. [PDF]

BMJ Open
Hameed M, Exarchou S, Eberhard A, Sharma A, Bergström U, Cagnotto G, Einarsson JT, Turesson C.   +7 more
europepmc   +1 more source

The temporal association between adverse drug reactions and antirheumatic drugs utilisation in Western Australia: a retrospective study from real-world data (1995-2015). [PDF]

Rheumatol Int
Almutairi KB, Inderjeeth CA, Inderjeeth CA, Preen DB, Keen HI, Nossent JC.   +5 more
europepmc   +1 more source

Association between disease-modifying antirheumatic drugs for rheumatoid arthritis and risk of incident dementia: a systematic review with meta-analysis. [PDF]

RMD Open
Xie W, Hou Y, Xiao S, Zhang X, Zhang Z.
europepmc   +1 more source

Incidence of Malignancies and the Association with Biological Disease-Modifying Antirheumatic Drugs in Japanese Patients with Rheumatoid Arthritis: A Time-Dependent Analysis from the IORRA Patient Registry. [PDF]

Rheumatol Ther
Harigai M, Tanaka E, Inoue E, Sakai R, Sugitani N, Toyoizumi S, Sugiyama N, Yamanaka H.   +7 more
europepmc   +1 more source

SULPHASALAZINE: A ‘NEW’ ANTIRHEUMATIC DRUG [PDF]

Rheumatology, 1984
Sulphasalazine was first introduced for the treatment of rheumatoid arthritis in 1942. Following initial enthusiasm, interest waned until 1978 when a large open study suggested that it might have a 'second-line effect'. Since then further studies have confirmed this effect and once again rheumatologists are starting to use sulphasalazine in the ...
Hilary A Capell, T. Pullar
openaire   +2 more sources

Disease-modifying antirheumatic drugs [PDF]

Nursing, 2010
Jennifer M. Belavic
openaire   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

The evaluation of antirheumatic drugs

Current Medical Research and Opinion, 1973
SummaryThe available methods of evaluation of an antirheumatic compound in a clinical trial situation are discussed. The techniques of single-blind and double-blind studies are described and their respective merits analysed. Proposed new techniques for the measurement of joint inflammation are reviewed.
W. C. Dick, Roger D. Sturrock, Alastair C. Kennedy, Peter Lee   +3 more
openaire   +3 more sources